Product/Composition:- | Penicillin G Injectable (IV, IM) |
---|---|
Strength:- | 1, 10, 20 million units / vial |
Form:- | Injectable (IV, IM) |
Reference Brands:- | Generics only |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Penicillin G inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, causing bacterial lysis and death. It is effective against severe infections like meningitis and pneumonia. Benefits include rapid bacterial eradication, proven efficacy, and safety when used appropriately, making it essential for treating life-threatening bacterial infections.
Penicillin G tablets are approved in the EU and US for treatment of severe bacterial infections, including meningitis, syphilis, and pneumonia. In the EU, these are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data, with biosimilar and generic options available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We help facilitate market access for Penicillin G, ensuring adherence to European and American standards for safe, effective antibiotic delivery.